Activation of TIM1 induces colon cancer cell apoptosis via modulating Fas ligand expression

Hao Wang1, Xueyan Zhang1, Wenjing Sun2

  • 1Department of Gastroenterology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150086, China.

Insights

Activation of TIM1 in colon cancer cells induces apoptosis, suggesting TIM1 as a potential therapeutic target for colon cancer treatment. This study explored TIM1

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The precise mechanisms driving colon cancer development remain incompletely understood.
  • Tumor-induced myeloidexpressed gene 1 (TIM1) has been implicated in various human cancers.
  • Investigating TIM1's role offers potential for novel therapeutic strategies in colon cancer.

Purpose of the Study:

  • To elucidate the function of TIM1 activation in suppressing human colon cancer cell proliferation.
  • To determine if TIM1 can serve as a therapeutic target for colon cancer.

Main Methods:

  • Cultured human colon cancer cell lines (HT29 and T84).
  • Assessed TIM1 expression using real-time RT-PCR and Western blotting.
  • Activated TIM1 with recombinant TIM4, analyzed apoptosis via flow cytometry, and examined FasL promoter activity using chromatin immunoprecipitation.

Main Results:

  • Both HT29 and T84 colon cancer cells express TIM1.
  • TIM1 activation by TIM4 significantly enhanced colon cancer cell apoptosis.
  • TIM4 treatment increased FasL expression, and blocking Fas/FasL pathways abrogated TIM4-induced apoptosis.

Conclusions:

  • TIM1 is expressed in human colon cancer cell lines HT29 and T84.
  • TIM1 activation effectively induces apoptosis in colon cancer cells.
  • TIM1 represents a promising novel therapeutic target for colon cancer intervention.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.8K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K